JPRN-jRCTs061230048招募中3 期
A Phase III Trial of the Efficacy and Safty of the Probiotics for the Prevention of Postoperative Infections after Lung Resection
Hamano Kimikazu0 个研究点目标入组 700 人开始时间: 2023年8月16日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) Outpatients or hospitalized patients scheduled for thoracoscopic anatomical lung resection (lobectomy or segmentectomy) for pulmonary lesions
- •(2) Patients suspected of primary lung cancer by CT or PET-CT, or diagnosed with primary lung cancer by bronchoscopy or CT-guided biopsy
- •(3) Patients aged 20 years or older at the time of informed consent
- •(4) Patients who have given written informed consent of their own free will after receiving sufficient explanation about participating in this study
排除标准
- •(1) Patients with a history of allergy to probiotics
- •(2) Patients with a history of side effects due to oral administration of probiotics
- •(3) Patients who have already received continuous administration of probiotics
- •(4) Patients who are currently taking probiotics regularly as guidance-required or over-the-counter drugs
- •(5) Patients undergoing treatment for any infectious disease
研究者
相似试验
进行中（未招募）
1 期
A Phase 3 Study to Evaluate Efficacy and Safety of a Single Dose of Exa-cel in Subjects with Severe Sickle Cell Disease, ßS/ßC GenotypeSickle cell anaemiaMedDRA version: 21.0Level: PTClassification code: 10040641Term: Sickle cell anaemia Class: 100000004850CTIS2023-503247-34-00Vertex Pharmaceuticals Inc.14
尚未招募
3 期
ow dose gemcitabine vs standard dose gemcitabine in advanced lung cancerCTRI/2013/02/003422Tata Memorial Hospital308
进行中（未招募）
1 期
A Phase 3 Evaluation of the Safety and Efficacy of Lambda/RBV/DCV in Treatment Naïve Subjects with Chronic HCV Infection, who have Underlying Mild or Moderate Hemophilia or Patients who are Prior Relapsers to Pegylated interferon alfa/RBVChronic Hepatitis C Virus Infection (Genotype 1, 2, 3, 4)MedDRA version: 14.1Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-003463-22-FRBristol-Myers Squibb International Corporation71
进行中（未招募）
3 期
A study to assess the safety and efficacy of a gel treatment in subjects with acne vulgarisAcne vulgarisSkin and Connective Tissue DiseasesISRCTN18067422PPM Services S.A400
招募中
3 期
A Phase 1/2/3 Study of the Safety and Efficacy of a Single Dose of Autologous CRISPR-Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (hHSPCs) in subjects with Transfusion-Dependent β-Thalassemia2024-516894-57-00Vertex Pharmaceuticals Inc.5